| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | A Nath | |
| K F Hauser | |||
| P E Knapp | |||
| J R Berger | |||
| S Buch | |||
| W R Tyor | |||
| N El-Hage | |||
| A J Bruce-Keller | |||
| P2860 | cites work | Chemokine receptors, neural progenitor cells, and the AIDS dementia complex | Q47293416 |
| The synergistic effects of NGF and IGF-1 on neurite growth in adult sensory neurons: convergence on the PI 3-kinase signaling pathway. | Q47698729 | ||
| The therapeutic use of heroin: a review of the pharmacological literature | Q22299321 | ||
| kappa opioid receptors in human microglia downregulate human immunodeficiency virus 1 expression | Q24315852 | ||
| Role of microglia in central nervous system infections | Q24563024 | ||
| Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication | Q27472939 | ||
| Morphine Enhances Hepatitis C Virus (HCV) Replicon Expression | Q27478396 | ||
| Free radicals in the physiological control of cell function | Q27860480 | ||
| Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery | Q27860586 | ||
| HIV-1 Tat protein down-regulates CREB transcription factor expression in PC12 neuronal cells through a phosphatidylinositol 3-kinase/AKT/cyclic nucleoside phosphodiesterase pathway | Q28142635 | ||
| Involvement of inositol 1,4,5-trisphosphate-regulated stores of intracellular calcium in calcium dysregulation and neuron cell death caused by HIV-1 protein tat | Q28145171 | ||
| Regulation of bad phosphorylation and association with Bcl-x(L) by the MAPK/Erk kinase | Q28145921 | ||
| PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms | Q28181035 | ||
| Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments | Q28211809 | ||
| Tat-induced deregulation of neuronal differentiation and survival by nerve growth factor pathway | Q28218398 | ||
| Effects of human immunodeficiency virus type 1 on astrocyte gene expression and function: potential role in neuropathogenesis | Q28246676 | ||
| Tat protein from HIV-1 activates MAP kinase in granular neurons and glial cells from rat cerebellum | Q28250735 | ||
| Human immunodeficiency virus type 1 and its coat protein gp120 induce apoptosis and activate JNK and ERK mitogen-activated protein kinases in human neurons | Q28256919 | ||
| Apoptotic death of striatal neurons induced by human immunodeficiency virus-1 Tat and gp120: Differential involvement of caspase-3 and endonuclease G | Q28267535 | ||
| Regulation of cell death protease caspase-9 by phosphorylation | Q28288607 | ||
| Extracellular human immunodeficiency virus type-1 Tat protein activates phosphatidylinositol 3-kinase in PC12 neuronal cells | Q28289237 | ||
| Sequential phosphorylation by mitogen-activated protein kinase and glycogen synthase kinase 3 represses transcriptional activation by heat shock factor-1 | Q28298063 | ||
| Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures | Q28330757 | ||
| Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro | Q28354326 | ||
| Opioid system diversity in developing neurons, astroglia, and oligodendroglia in the subventricular zone and striatum: impact on gliogenesis in vivo | Q28360384 | ||
| HIV-1 Tat-mediated activation of glycogen synthase kinase-3beta contributes to Tat-mediated neurotoxicity | Q28369830 | ||
| Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN | Q28513537 | ||
| Activation of glycogen synthase kinase 3 beta (GSK-3beta) by platelet activating factor mediates migration and cell death in cerebellar granule neurons | Q28565001 | ||
| Stromal cell-derived factor 1-mediated CXCR4 signaling in rat and human cortical neural progenitor cells | Q28576470 | ||
| PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway | Q28588309 | ||
| Regulation of PTEN transcription by p53 | Q28646911 | ||
| Regulation of neuronal survival by the serine-threonine protein kinase Akt | Q29614185 | ||
| The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase | Q29618387 | ||
| U50,488 inhibits HIV-1 Tat-induced monocyte chemoattractant protein-1 (CCL2) production by human astrocytes | Q44243149 | ||
| Lithium ameliorates HIV-gp120-mediated neurotoxicity | Q44260038 | ||
| Involvement of central mu- but not delta- or kappa-opioid receptors in immunomodulation | Q44332949 | ||
| Modulation of humoral immune responses in the rat by centrally applied Met-Enk and opioid receptor antagonists: functional interactions of brain OP1, OP2 and OP3 receptors. | Q44333133 | ||
| Characterization of opioid-dependent glial development in dissociated and organotypic cultures of mouse central nervous system: critical periods and target specificity | Q44335826 | ||
| Bimodal opioid regulation of cyclic AMP formation: implications for positive and negative coupling of opiate receptors to adenylyl cyclase | Q44336792 | ||
| Mu- and delta-opioid receptor antagonists decrease proliferation and increase neurogenesis in cultures of rat adult hippocampal progenitors | Q44341038 | ||
| Opioid-induced proliferation through the MAPK pathway in cultures of adult hippocampal progenitors | Q44342043 | ||
| Primary astroglial cultures derived from several rat brain regions differentially express mu, delta and kappa opioid receptor mRNA. | Q44342405 | ||
| Phosphoinositide 3-kinase cascade facilitates mu-opioid desensitization in sensory neurons by altering G-protein-effector interactions. | Q44343456 | ||
| Mu opioid transactivation and down-regulation of the epidermal growth factor receptor in astrocytes: implications for mitogen-activated protein kinase signaling | Q44343749 | ||
| Heterodimerization and cross-desensitization between the mu-opioid receptor and the chemokine CCR5 receptor | Q44344210 | ||
| Morphine inhibits Fc-mediated phagocytosis through mu and delta opioid receptors | Q44344271 | ||
| HIV infection and high-risk behaviors in opioid dependent patients: the Indian context | Q44346855 | ||
| Agonist-mediated tyrosine phosphorylation of isoforms of the shc adapter protein by the delta opioid receptor | Q44347369 | ||
| Delta-opioid receptors on astroglial cells in primary culture: mobilization of intracellular free calcium via a pertussis sensitive G protein. | Q44349452 | ||
| Kappa-opioid modulation of human microglial cell superoxide anion generation | Q44349979 | ||
| Delta-opioid suppression of human immunodeficiency virus-1 expression in T cells (Jurkat). | Q44349985 | ||
| Delta-opioid receptor immunoreactivity on astrocytes is upregulated during mitosis | Q44351369 | ||
| Endomorphin-1 potentiates HIV-1 expression in human brain cell cultures: implication of an atypical mu-opioid receptor | Q44351901 | ||
| Differential kappa-opioid receptor expression on mouse lymphocytes at varying stages of maturation and on mouse macrophages after selective elicitation | Q44352377 | ||
| MAP kinase activation by mu opioid receptor involves phosphatidylinositol 3-kinase but not the cAMP/PKA pathway | Q44352609 | ||
| Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120. | Q44532346 | ||
| Morphine suppresses lymphocyte apoptosis by blocking p53-mediated death signaling | Q44555485 | ||
| HIV risk differences between African-American and white men who have sex with men. | Q44624406 | ||
| Withdrawal from morphine in mice suppresses splenic macrophage function, cytokine production, and costimulatory molecules | Q44641628 | ||
| Paradoxes of immunosuppression in mouse models of withdrawal | Q44740871 | ||
| Morphine modulates HIV-1 gp160-induced murine macrophage and human monocyte apoptosis by disparate ways. | Q44771323 | ||
| Chemokine receptors are expressed widely by embryonic and adult neural progenitor cells | Q44817634 | ||
| Drugs of abuse and HIV--a perspective | Q44926764 | ||
| In vivo effects of cocaine on immune cell function | Q44987163 | ||
| Effects of human immunodeficiency virus encephalitis and drug abuse on the B lymphocyte population of the brain | Q45626152 | ||
| Growth hormone prevents human immunodeficiency virus-induced neuronal p53 expression | Q45710538 | ||
| Caspase cascades in human immunodeficiency virus-associated neurodegeneration. | Q45732507 | ||
| Neuropathology in non-human immunodeficiency virus-infected drug addicts: hypoxic brain damage after chronic intravenous drug abuse | Q45768664 | ||
| Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome | Q45782617 | ||
| beta-Endorphin enhances the replication of neurotropic human immunodeficiency virus in fetal perivascular microglia. | Q45788836 | ||
| Increased expression of tumor necrosis factor-alpha receptors in the brains of patients with AIDS. | Q46181561 | ||
| Multiple ways that drug abuse might influence AIDS progression: clues from a monkey model | Q47245276 | ||
| Molecular basis for interactions of HIV and drugs of abuse. | Q30332159 | ||
| The neuropathology of heroin abuse. | Q30611952 | ||
| Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection | Q30883324 | ||
| Mu-opioid receptor activation prevents apoptosis following serum withdrawal in differentiated SH-SY5Y cells and cortical neurons via phosphatidylinositol 3-kinase. | Q33186448 | ||
| Dystonia in AIDS: report of four cases | Q33195932 | ||
| Multiple roles for PI 3-kinase in the regulation of PLCgamma activity and Ca2+ mobilization in antigen-stimulated mast cells. | Q33542046 | ||
| Do alcohol and cocaine abuse alter the course of HIV-associated dementia complex? | Q33594726 | ||
| Diversity of the endogenous opioid system in development. Novel signal transduction translates multiple extracellular signals into neural cell growth and differentiation. | Q33758935 | ||
| The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. | Q33783562 | ||
| Pathobiology of human immunodeficiency virus dementia | Q33863784 | ||
| Serine/threonine protein kinases and apoptosis. | Q33876765 | ||
| Viral exploitation and subversion of the immune system through chemokine mimicry | Q33933260 | ||
| HIV-1 infected mononuclear phagocyte secretory products affect neuronal physiology leading to cellular demise: relevance for HIV-1-associated dementia. | Q33952997 | ||
| Pain control by immune-derived opioids | Q33955138 | ||
| Detection and function of opioid receptors on cells from the immune system | Q33998561 | ||
| Molecular neurobiology of addiction | Q34093147 | ||
| Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia | Q34098776 | ||
| Inhibition by naloxone stereoisomers of beta-amyloid peptide (1-42)-induced superoxide production in microglia and degeneration of cortical and mesencephalic neurons | Q34144951 | ||
| Opioids, opioid receptors, and the immune response | Q34179298 | ||
| Bidirectional heterologous desensitization of opioid and chemokine receptors | Q34194750 | ||
| Visualization of O-2A progenitor cells in developing and adult rat optic nerve by quisqualate-stimulated cobalt uptake | Q34207013 | ||
| Pathways to neuronal injury and apoptosis in HIV-associated dementia. | Q34223078 | ||
| A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium | Q34254567 | ||
| Neuropsychiatric impact of hepatitis C on advanced HIV | Q34313868 | ||
| Redox signaling in macrophages | Q34419260 | ||
| Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons. | Q34462515 | ||
| The GSK3 beta signaling cascade and neurodegenerative disease. | Q34671410 | ||
| The opioid-cytokine connection | Q34747504 | ||
| Microglia in human immunodeficiency virus-associated neurodegeneration. | Q34963796 | ||
| HIV and drug misuse in the Edinburgh cohort | Q34978063 | ||
| Preferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro. | Q35009483 | ||
| Morphine inhibits Purkinje cell survival and dendritic differentiation in organotypic cultures of the mouse cerebellum | Q35012855 | ||
| Selective vulnerability of cerebellar granule neuroblasts and their progeny to drugs with abuse liability | Q35014175 | ||
| Regulation of cell survival and proliferation by the FOXO (Forkhead box, class O) subfamily of Forkhead transcription factors | Q35053112 | ||
| Opioid G protein-coupled receptors: signals at the crossroads of inflammation | Q35077145 | ||
| Opioids modulate cell division in the germinal zone of the late embryonic neocortex | Q48130574 | ||
| Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon | Q48192959 | ||
| Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis | Q48235017 | ||
| Cytokine regulation of CC and CXC chemokine expression by human astrocytes | Q48246768 | ||
| The neuropathology of adult HIV infection. | Q48291701 | ||
| HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress | Q48313745 | ||
| The AIDS dementia complex: II. Neuropathology | Q48340087 | ||
| HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement | Q48343313 | ||
| ? andk opiate receptors in primary astroglial cultures part II: Receptor sets in cultures from various brain regions and interactions with �-receptor activated cyclic AMP | Q48478440 | ||
| Cytokine expression in the brain during the acquired immunodeficiency syndrome | Q48496332 | ||
| Primary headaches in HIV-infected patients | Q48568803 | ||
| Downregulation of MAP kinase activity signalled by HIV-1-gp120 coat protein in granular neurons and glial cells from rat cerebellum. | Q48586414 | ||
| mu-Opioids activate tyrosine kinase focal adhesion kinase and regulate cortical cytoskeleton proteins cortactin and vinculin in chick embryonic neurons | Q48596665 | ||
| Mu and delta opiate receptors in neuronal and astroglial primary cultures from various regions of the brain--coupling with adenylate cyclase, localisation on the same neurones and association with dopamine (D1) receptor adenylate cyclase | Q48636546 | ||
| HIV-associated brain pathology in the United Kingdom: an epidemiological study | Q48657818 | ||
| Morphine stimulates phagocytosis of Mycobacterium tuberculosis by human microglial cells: involvement of a G protein-coupled opiate receptor. | Q52274096 | ||
| Opioids disrupt Ca2+ homeostasis and induce carbonyl oxyradical production in mouse astrocytes in vitro: transient increases and adaptation to sustained exposure. | Q52530654 | ||
| Increased vulnerability of ApoE4 neurons to HIV proteins and opiates: protection by diosgenin and L-deprenyl. | Q54601885 | ||
| Neurological and neuropshychological manifestations of HIV-1 infection: Association with AIDS-related complex but not asymptomatic HIV-1 infection | Q56989910 | ||
| High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice | Q58378937 | ||
| Differential signalling of the chemokine receptor CXCR4 by stromal cell-derived factor 1 and the HIV glycoprotein in rat neurons and astrocytes | Q58794846 | ||
| CD4 cell recovery during successful antiretroviral therapy in naive HIV-infected patients | Q58868742 | ||
| Morphine potentiates transforming growth factor-beta release from human peripheral blood mononuclear cell cultures | Q68196916 | ||
| Effects of methadone-HCl on dorsal root ganglia in organotypic culture | Q69542868 | ||
| Morphine-induced delay of normal cell death in the avian ciliary ganglion | Q70091235 | ||
| Linkage of G protein-coupled receptors to the MAPK signaling pathway through PI 3-kinase gamma | Q71970954 | ||
| Differential induction of the interleukin-6 gene by tumor necrosis factor and interleukin-1 | Q72068674 | ||
| Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor | Q72121269 | ||
| Clinical-neuropathologic correlation in HIV-associated dementia | Q72586517 | ||
| A regulatory role for astrocytes in HIV-1 encephalitis. An overexpression of eicosanoids, platelet-activating factor, and tumor necrosis factor-alpha by activated HIV-1-infected monocytes is attenuated by primary human astrocytes | Q72646593 | ||
| Neuropathologic analysis of postmortal brain samples of HIV-seropositive and -seronegative i.v. drug addicts | Q72754245 | ||
| Morphine enhances interleukin-12 and the production of other pro-inflammatory cytokines in mouse peritoneal macrophages | Q73176412 | ||
| Expression of caspase-3 in brains from paediatric patients with HIV-1 encephalitis | Q73189533 | ||
| Substance abuse and HIV infection | Q73322298 | ||
| Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia | Q73542588 | ||
| Tumor necrosis factor is required for RANTES-induced astrocyte monocyte chemoattractant protein-1 production | Q73601961 | ||
| Relationship of Nef-positive and GFAP-reactive astrocytes to drug use in early and late HIV infection | Q73725858 | ||
| Partial opioids. Medications for the treatment of pain and drug abuse | Q74057729 | ||
| Functional cross-talk of HIV-1 Tat with p53 through its C-terminal domain | Q74507066 | ||
| Association of drug abuse with inhibition of HIV-1 immune responses: studies with long-term of HIV-1 non-progressors | Q75326358 | ||
| Does drug abuse influence the microglial response in AIDS and HIV encephalitis? | Q79906302 | ||
| Anti-inflammatory effects of opioids | Q35078254 | ||
| mu-Opioid receptor-induced Ca2+ mobilization and astroglial development: morphine inhibits DNA synthesis and stimulates cellular hypertrophy through a Ca(2+)-dependent mechanism | Q35112431 | ||
| Human immunodeficiency virus type 1 infection of human brain-derived progenitor cells | Q35123435 | ||
| Chemokine receptors: signposts to brain development and disease | Q35141737 | ||
| Opiates and immune function. Consequences on infectious diseases with special reference to AIDS | Q35221711 | ||
| The role of monocyte/macrophages and cytokines in the pathogenesis of HIV infection | Q35353199 | ||
| Adherence to heroin dependence therapies and human immunodeficiency virus/acquired immunodeficiency syndrome infection rates among drug abusers | Q35597341 | ||
| The dynamics of substance use and sex networks in HIV transmission | Q35624692 | ||
| Interaction between HIV and intravenous heroin abuse? | Q35637420 | ||
| G protein-coupled receptor dimerization: function and ligand pharmacology | Q35814850 | ||
| Chemotaxis receptors and signaling | Q35925892 | ||
| Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia | Q35980114 | ||
| Glia and volume transmission during physiological and pathological states | Q35984454 | ||
| Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease | Q36232123 | ||
| Interleukin 3-dependent survival by the Akt protein kinase | Q36593239 | ||
| Glial growth is regulated by agonists selective for multiple opioid receptor types in vitro | Q36758842 | ||
| Requirement of receptor internalization for opioid stimulation of mitogen-activated protein kinase: biochemical and immunofluorescence confocal microscopic evidence | Q36824461 | ||
| Mu-opioid agonist inhibition of kappa-opioid receptor-stimulated extracellular signal-regulated kinase phosphorylation is dynamin-dependent in C6 glioma cells | Q36946620 | ||
| Opioid modulation of extracellular signal-regulated protein kinase activity is ras-dependent and involves Gbetagamma subunits | Q36982854 | ||
| In vivo and in vitro studies of opiates and cellular immunity in narcotic addicts | Q37512049 | ||
| Modulation by morphine of viral set point in rhesus macaques infected with simian immunodeficiency virus and simian-human immunodeficiency virus | Q37567921 | ||
| Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons | Q37874601 | ||
| Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection | Q37925515 | ||
| Neuroimmunomodulation by opiates and other drugs of abuse: relationship to HIV infection and AIDS. | Q39512395 | ||
| Mu-opioid induction of monocyte chemoattractant protein-1, RANTES, and IFN-gamma-inducible protein-10 expression in human peripheral blood mononuclear cells | Q39588585 | ||
| Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy | Q40438055 | ||
| HIV-1 promotes quiescence in human neural progenitor cells | Q40541870 | ||
| Interactions of opioid and chemokine receptors: oligomerization of mu, kappa, and delta with CCR5 on immune cells | Q40692753 | ||
| Morphine regulates gene expression of alpha- and beta-chemokines and their receptors on astroglial cells via the opioid mu receptor | Q40702376 | ||
| Role of p38 mitogen-activated protein kinase phosphorylation and Fas-Fas ligand interaction in morphine-induced macrophage apoptosis. | Q40739727 | ||
| A review of neuronal damage in human immunodeficiency virus infection: its assessment, possible mechanism and relationship to dementia | Q40775409 | ||
| Opioids, receptors, and immunity | Q40778862 | ||
| Enhancement of HIV-1 replication by opiates and cocaine: the cytokine connection | Q40778881 | ||
| Mechanisms of morphine-induced immunomodulation | Q40856607 | ||
| Multiple polyphosphoinositide pathways regulate apoptotic signalling in a dorsal root ganglion derived cell line | Q40902275 | ||
| Overexpression of Akt (protein kinase B) confers protection against apoptosis and prevents formation of ceramide in response to pro-apoptotic stimuli | Q40932374 | ||
| The opposing roles of the Akt and c-Myc signalling pathways in survival from CD95-mediated apoptosis | Q40982924 | ||
| Exogenous and endogenous opioids as biological response modifiers | Q41001683 | ||
| mu-Opioid receptor activates signaling pathways implicated in cell survival and translational control | Q41012113 | ||
| Opiate effects on in vitro human retroviral infection | Q41024929 | ||
| Cyclic AMP protects against staurosporine and wortmannin-induced apoptosis and opioid-enhanced apoptosis in both embryonic and immortalized (F-11kappa7) neurons | Q41055527 | ||
| Selective interactions of mu-opioid receptors with pertussis toxin-sensitive G proteins: involvement of the third intracellular loop and the c-terminal tail in coupling | Q41071297 | ||
| Mitogenic signalling by delta opioid receptors expressed in rat-1 fibroblasts involves activation of the p70s6k/p85s6k S6 kinase | Q41102257 | ||
| Chronic exposure to kappa-opioids enhances the susceptibility of immortalized neurons (F-11kappa 7) to apoptosis-inducing drugs by a mechanism that may involve ceramide. | Q41108497 | ||
| Neurotoxic versus neuroprotective actions of endogenous opioid peptides: implications for treatment of CNS injury. | Q41114012 | ||
| The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. | Q41120735 | ||
| Endogenous opioids modulate neuronal survival in the developing avian ciliary ganglion | Q41131572 | ||
| kappa-opioid receptor expression defines a phenotypically distinct subpopulation of astroglia: relationship to Ca2+ mobilization, development, and the antiproliferative effect of opioids | Q41132298 | ||
| The relevance of opioids and opioid receptors on immunocompetence and immune homeostasis | Q41293964 | ||
| Immunomodulatory role of opioids in the central nervous system | Q41686241 | ||
| HIV dementia and the basal ganglia | Q41693843 | ||
| The neuropathogenesis of the AIDS dementia complex. | Q41694913 | ||
| Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat. | Q41841039 | ||
| Regional, developmental, and cell cycle-dependent differences in mu, delta, and kappa-opioid receptor expression among cultured mouse astrocytes | Q41943142 | ||
| Morphine negatively regulates interferon-gamma promoter activity in activated murine T cells through two distinct cyclic AMP-dependent pathways | Q42169348 | ||
| Morphine enhances macrophage apoptosis. | Q42450969 | ||
| Neuroprotective activities of sodium valproate in a murine model of human immunodeficiency virus-1 encephalitis. | Q42451198 | ||
| Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia | Q42474669 | ||
| Delta and kappa opiate receptors in primary astroglial cultures from rat cerebral cortex | Q42475205 | ||
| Upregulation of microglia in drug users with and without pre-symptomatic HIV infection | Q42479974 | ||
| Opioid-dependent growth of glial cultures: suppression of astrocyte DNA synthesis by met-enkephalin | Q42483511 | ||
| Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia | Q42512061 | ||
| Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway | Q42618265 | ||
| Activation of mu opioid receptors inhibits microglial cell chemotaxis | Q42656128 | ||
| Macrophage colony-stimulating factor promotes cell survival through Akt/protein kinase B. | Q42811250 | ||
| Conditional inhibition of the mitogen-activated protein kinase cascade by wortmannin. Dependence on signal strength | Q42834737 | ||
| Activated phosphatidylinositol 3-kinase and Akt kinase promote survival of superior cervical neurons | Q42840914 | ||
| Depolarization and neurotrophins converge on the phosphatidylinositol 3-kinase-Akt pathway to synergistically regulate neuronal survival | Q42911158 | ||
| Detection of hepatitis C virus genomic sequences in the cerebrospinal fluid of HIV-infected patients. | Q42985465 | ||
| The effects of interaction between morphine and interleukin-1 on the immune response. | Q43070863 | ||
| Cocaine abuse and HIV-1 infection: epidemiology and neuropathogenesis | Q43070984 | ||
| Opiates as potential cofactors in progression of HIV-1 infections to AIDS. | Q43070988 | ||
| Evidence for opioid receptors on cells involved in host defense and the immune system | Q43070996 | ||
| Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations | Q43070999 | ||
| Evidence for central opioid receptors in the immunomodulatory effects of morphine: review of potential mechanism(s) of action | Q43071003 | ||
| Phenytoin, midazolam, and naloxone protect against fentanyl-induced brain damage in rats | Q43510645 | ||
| U50488 inhibits HIV-1 expression in acutely infected monocyte-derived macrophages | Q43540771 | ||
| Protective effects of morphine in peroxynitrite-induced apoptosis of primary rat neonatal astrocytes: potential involvement of G protein and phosphatidylinositol 3-kinase (PI3 kinase). | Q43557316 | ||
| Kappa-opioid receptor agonist suppression of HIV-1 expression in CD4+ lymphocytes | Q43574324 | ||
| Changes in the expression of glial glutamate transporters in the rat brain accompanied with morphine dependence and naloxone-precipitated withdrawal | Q43651505 | ||
| Glutamate, NMDA, and AMPA induced changes in extracellular space volume and tortuosity in the rat spinal cord. | Q43721378 | ||
| Kappa-opioid receptor ligands inhibit cocaine-induced HIV-1 expression in microglial cells | Q43721413 | ||
| Mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine abuse: synthesis and opioid receptor binding affinity of N-substituted derivatives of morphinan | Q43759911 | ||
| The AIDS dementia complex: I. Clinical features | Q43769670 | ||
| Inhibition of HIV-1 gp120-induced apoptosis in neuroblastoma SK-N-SH cells by an antisense oligodeoxynucleotide against p53. | Q43778480 | ||
| Chronic morphine exposure increases the phosphorylation of MAP kinases and the transcription factor CREB in dorsal root ganglion neurons: an in vitro and in vivo study | Q43782521 | ||
| Opiates promote T cell apoptosis through JNK and caspase pathway | Q43811683 | ||
| The neuropathologic effects in rats and neurometabolic effects in humans of large-dose remifentanil | Q43969865 | ||
| Morphine induces apoptosis of human microglia and neurons | Q43996588 | ||
| Chronic morphine induces downregulation of spinal glutamate transporters: implications in morphine tolerance and abnormal pain sensitivity. | Q44132630 | ||
| The fibroblast growth factor receptor is at the site of convergence between mu-opioid receptor and growth factor signaling pathways in rat C6 glioma cells | Q44220833 | ||
| P433 | issue | 1-2 | |
| P921 | main subject | HIV/AIDS | Q12199 |
| substance abuse | Q3184856 | ||
| P304 | page(s) | 63-80 | |
| P577 | publication date | 2005-10-01 | |
| P1433 | published in | Neurotoxicity Research | Q15764278 |
| P1476 | title | Molecular targets of opiate drug abuse in neuroAIDS. | |
| P478 | volume | 8 |
| Q36839084 | A Bivalent Ligand Targeting the Putative Mu Opioid Receptor and Chemokine Receptor CCR5 Heterodimers: Binding Affinity versus Functional Activities |
| Q37570243 | A novel bivalent HIV-1 entry inhibitor reveals fundamental differences in CCR5-μ-opioid receptor interactions between human astroglia and microglia |
| Q34209473 | Alterations of CXCR4 function in μ-opioid receptor-deficient glia |
| Q54455120 | Astrocytes are a neural target of morphine action via glucocorticoid receptor-dependent signaling. |
| Q37015533 | Battle of animal models |
| Q35216669 | Bivalent ligands targeting chemokine receptor dimerization: molecular design and functional studies |
| Q43123425 | CCR2 mediates increases in glial activation caused by exposure to HIV-1 Tat and opiates |
| Q46334332 | Cannabinoid rescue of striatal progenitor cells in chronic Borna disease viral encephalitis in rats |
| Q91846883 | Combined HIV-1 Tat and oxycodone activate the hypothalamic-pituitary-adrenal and -gonadal axes and promote psychomotor, affective, and cognitive dysfunction in female mice |
| Q35220086 | Design and synthesis of a bivalent ligand to explore the putative heterodimerization of the mu opioid receptor and the chemokine receptor CCR5. |
| Q37064333 | Differential expression and HIV-1 regulation of μ-opioid receptor splice variants across human central nervous system cell types |
| Q37610922 | Differential expression of the alternatively spliced OPRM1 isoform μ-opioid receptor-1K in HIV-infected individuals |
| Q35818267 | Differing roles of autophagy in HIV-associated neurocognitive impairment and encephalitis with implications for morphine co-exposure |
| Q28750204 | Disruption of neuronal CXCR4 function by opioids: preliminary evidence of ferritin heavy chain as a potential etiological agent in neuroAIDS |
| Q99713341 | Effect of Opioid Use on Immune Activation and HIV Persistence on ART |
| Q37950301 | Epigenetics of µ-opioid receptors: intersection with HIV-1 infection of the central nervous system |
| Q40487821 | Exploration of bivalent ligands targeting putative mu opioid receptor and chemokine receptor CCR5 dimerization |
| Q28569735 | Expression of the mu opioid receptor in the human immunodeficiency virus type 1 transgenic rat model |
| Q35779848 | Fractalkine/CX3CL1 protects striatal neurons from synergistic morphine and HIV-1 Tat-induced dendritic losses and death |
| Q38917051 | GSK3β-activation is a point of convergence for HIV-1 and opiate-mediated interactive neurotoxicity |
| Q37210259 | GTPgammaS incorporation in the rat brain: a study on mu-opioid receptors and CXCR4. |
| Q34797566 | HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines |
| Q35009465 | HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse |
| Q47105347 | Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvant |
| Q37015405 | Impact of opiate-HIV-1 interactions on neurotoxic signaling |
| Q35007339 | Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors |
| Q35996523 | Interactive Effects of Morphine on HIV Infection: Role in HIV-Associated Neurocognitive Disorder |
| Q34086976 | Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons |
| Q35857045 | Morphine and gp120 toxic interactions in striatal neurons are dependent on HIV-1 strain |
| Q37301018 | Morphine causes rapid increases in glial activation and neuronal injury in the striatum of inducible HIV-1 Tat transgenic mice |
| Q36109980 | Morphine efficacy is altered in conditional HIV-1 Tat transgenic mice. |
| Q28474433 | Morphine exacerbates HIV-1 Tat-induced cytokine production in astrocytes through convergent effects on [Ca(2+)](i), NF-kappaB trafficking and transcription |
| Q36687603 | Morphine exposure during HIV encephalitis in SCID mice |
| Q28566402 | Morphine increases brain levels of ferritin heavy chain leading to inhibition of CXCR4-mediated survival signaling in neurons |
| Q35606725 | Morphine potentiates neurodegenerative effects of HIV-1 Tat through actions at μ-opioid receptor-expressing glia |
| Q23915009 | NeuroAIDS, drug abuse, and inflammation: building collaborative research activities |
| Q36696105 | Neurotoxins and neurotoxicity mechanisms. An overview. |
| Q35763921 | Opiate addiction therapies and HIV-1 Tat: interactive effects on glial [Ca²⁺]i, oxyradical and neuroinflammatory chemokine production and correlative neurotoxicity. |
| Q36201412 | Opiate drug use and the pathophysiology of neuroAIDS. |
| Q33842214 | Opioids and Opioid Maintenance Therapies: Their Impact on Monocyte-Mediated HIV Neuropathogenesis |
| Q26742182 | Opioids and Viral Infections: A Double-Edged Sword |
| Q34112578 | Pain and opioid addiction: what is the connection? |
| Q36505623 | Regulation and Functional Implications of Opioid Receptor Splicing in Opioid Pharmacology and HIV Pathogenesis |
| Q37133136 | Role of mu-opioids as cofactors in human immunodeficiency virus type 1 disease progression and neuropathogenesis |
| Q35236345 | Sensitization of enteric neurons to morphine by HIV-1 Tat protein. |
| Q38866412 | Simian Immunodeficiency Virus Impacts MicroRNA-16 Mediated Post-Transcriptional Regulation of mu Opioid Receptor in CEM ×174 Cells |
| Q36218958 | Therapeutical Neurotargeting via Magnetic Nanocarrier: Implications to Opiate-Induced Neuropathogenesis and NeuroAIDS. |
| Q46522622 | Tight junction regulation by morphine and HIV-1 tat modulates blood-brain barrier permeability |
| Q34495140 | Towards nanomedicines for neuroAIDS. |
Search more.